Below is a selection of Dr. Hynicka’s publications and presentations
Peer Reviewed Publications
Hynicka LM, Khambaty M. Angioedema secondary to sofosbuvir/ledipasvir. Ann Pharmacother 2016; accepted for publication.
Hynicka LM, Heil EL. Hepatitis C treatment exposed or experienced? Ann Pharmacother 2016;epub ahead of print.
Wiener ES, Heil EL, Hynicka LM, Johnson JK. Are fluoroquinolones appropriate for the treatment of extended-spectum β-lactamase-producing gram-negative bacilli? J Pharm Technol 2016;32:16-21.
Heil E, Hynicka LM, Kottili S, Tang L.What does the pharmacologic future of treating chronic hepatitis C look like? Expert Rev Clin Pharmacol 2015;8:605-22.
Hynicka LM. Myxedema madness: a case for short-term antipsychotics? Ann Pharmacother 2015;49:607-8.
Meaney CJ*, Hynicka LM, Tsoukleris MG. Vancomycin associated nephrotoxicity in adult medicine patients: incidence, outcomes, and risk factors. Pharmacotherapy 2014; 34:653-61.
Fleming E*, Heil E, Hynicka LM. Treatment strategy for a multidrug-resistant klebsiella UTI: A case report. Ann Pharmacother 2014; 48:123-7.
Pincus K, Hynicka LM. Prophylaxis of thromboembolic events in patients with nephrotic syndrome. Ann Pharmacother 2013; 47:725-34.
Hynicka LM, Heil EL.Anemia management in patients with chronic viral hepatitis C. Ann Pharmacother 2013;47:228-36
Kim M*, Hynicka LM. Azithromycin-induced hepatotoxicity. Hosp Pharm 2012;47:946-9.
Hynicka LM, Silva KN. Probable rifaximin-induced neutropenia. Am J Health Syst Pharm 2012;69:583-6.
Hynicka LM, Ensor CR. Prophylaxis and treatment of respiratory syncytial virus in adult immunocompromised patients. Ann Pharmacother 2012;46:558-66.
Hynicka LM, Yunker N, Patel PH. A review of oral antiretroviral therapy for the treatment of chronic hepatitis B. Ann Pharmacother 2010.
Fulco PP, Hynicka L, Rackley D. Raltegravir-based HAART regimen in a patient with large b-cell lymphoma. Ann Pharmacother 2010;44:377-82.
Hynicka LM, Cahoon WD, Bukaveckas B. Genetic testing for warfarin therapy initiation. Ann Pharmacother 2008;42:1298-1303.
Skledar SJ, McKaveney TP, Sokos DR, Ervin KA, Coldren M, Hynicka L, Lavsa S, Reynolds R, Beauchamp R. The role of student pharmacists in a hospital-based standing orders pneumococcal vaccination program. J Am Pharm Assoc 2007;27:404-9.
Presentations
Dunn EE, Mattingly II TJ, Vranek K, Hynicka LM, Gripshover JL, Potosky DR. Evaluating a team-based approach to improve health-system navigation and efficiency in the treatment of hepatitis C virus (HCV). Poster. American Society of Health-Systems Pharmacists Midyear Clinical Meeting, December 2015.
Gao A, Hynicka LM. Communication and access: a focus on transitions of care. Poster. American Society of Health-System Pharmacists 2013 Midyear Clinical Meeting, December 2014.
Cheng AM, Hynicka LM, Pajoumand M, Zimrin AB. Accuracy of diagnosing heparin-induced thrombocytopenia (HIT) with serologic tests and clinical scoring models. Poster. American Society of Health-System Pharmacists 2013 Midyear Clinical Meeting, December 2013.
Maharaj NA, Wang AY, Devabhakthuni S, Hynicka LM. Erythropoietin stimulating agent use in adult medicine patients during acute hospitalization. Poster. American Society of Health-System Pharmacists 2013 Midyear Clinical Meeting, December 2013.
Lee S, Good B, Hynicka L, Heil E. Evaluation of the therapeutic drug monitoring process at a university medical center for quality improvement. Poster. American Society of Health-System Pharmacists 2013 Midyear Clinical Meeting, December 2013.
Simon CC, Hynicka LM, Watson K, Onukwagha E. Time of income receipt and effects on heart failure exacerbations during the course of a month. Poster. American Society of Health-System Pharmacists 2012 Midyear Clinical Meeting, December 2012.
Flurie RW, Heil E, Hynicka L. Evaluations of anemia rates in HCV patients initiated on telaprevir. Poster. UHC Poster Session at the American Society of Health-System Pharmacists 2012 Midyear Clinical Meeting, December 2012.
Good B, Hynicka L. Evaluation of the therapeutic drug monitoring process at a university medical center for quality improvement. Poster. American Society of Health-System Pharmacists 2011 Midyear Clinical Meeting, December 2011.
Smith JM, Sheth N, Hynicka L, Riedel D. Use of concurrent antiretroviral medications and chemotherapeutic agents: a retrospective review. Poster. American Society of Health-System Pharmacists 2011 Midyear Clinical Meeting, December 2011.
Meaney C, Hynicka L, Badowski M, Tsoukleris M. Assessment of the rate of vancomycin nephrotoxicity in adult medicine patients at a large tertiary care medical center. Poster. American Society of Health-System Pharmacists 2011 Midyear Clinical Meeting, December 2011.
Burakgazi E, Hynicka L, Towne A, Pellock J. The use of intravenous levetiracetam in epilepsy patients and its efficacy . Poster. American Epilepsy Society Annual Meeting, December 2008.
Hynicka LM, Fulco P. Characterization of raltegravir use in an infectious disease clinic at a large academic institution. Poster. UHC Poster Session at the American Society of Health-System Pharmacists 2008 Midyear Clinical Meeting, December 2008
Hynicka LM, Potter T. Evaluation of intravenous levetiracetam in a large tertiary care teaching hospital. Poster. American Society of Health-System Pharmacists 2008 Midyear Clinical Meeting, December 2008.
Hynicka LM, Potter T. Evaluation of the use of intravenous levetiracetam. Poster. UHC Poster Session at the American Society of Health-System Pharmacists 2007 Midyear Clinical Meeting, December 2007.
Hynicka LM, Donihi AC, Sirio CA, et al. Inpatient medication therapy management within the Enhanced Patient Safety Intervention to Optimize Medication Education (EPITOME). Poster. American Society of Health-System Pharmacists 2006 Midyear Clinical Meeting, December 2006.
Lavsa SM, Hynicka LM, Skledar SJ, et al. Monitoring acetaminophen dosing: a safety evaluation. Poster. American Society of Health-System Pharmacists 2006 Midyear Clinical Meeting, December 2006.
Hynicka LM, Ervin KC, Skledar SJ, et al. The pharmacy students’ role in a standing order pneumococcal vaccine program American Society of Health- System Pharmacists 2004 Midyear Clinical December 2004.